ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
$03
About Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Details
Daily high
$17.75
Daily low
$15.92
Price at open
--
52 Week High
$24.17
52 Week Low
$5.50
Market cap
455.6M
Dividend yield
-
Volume
11,950
Avg. volume
1.2M
P/E ratio
-4.84
Arcturus Therapeutics Holdings Inc. - Common Stock News
Details
Daily high
$17.75
Daily low
$15.92
Price at open
--
52 Week High
$24.17
52 Week Low
$5.50
Market cap
455.6M
Dividend yield
-
Volume
11,950
Avg. volume
1.2M
P/E ratio
-4.84